Evidence map›Paper›PMID 24191005›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Regulation of OSR1 and the sodium, potassium, two chloride cotransporter by convergent signals.

Samarpita Sengupta, Andrés Lorente-Rodríguez, Svetlana Earnest, Steve Stippec, Xiaofeng Guo, David C Trudgian, Hamid Mirzaei, Melanie H Cobb

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. UBR5 is a novel regulator of WNK1 stability.American journal of physiology. Cell physiology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Lysosome: The metabolic signaling hub.Traffic (Copenhagen, Denmark) · 2019
    Review
  17. Review
  18. Hypertension: the missing WNKs.American journal of physiology. Renal physiology · 2016
    Review
  19. Review
  20. Generation of WNK1 knockout cell lines by CRISPR/Cas-mediated genome editing.American journal of physiology. Renal physiology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Samarpita SenguptaDepartments of Pharmacology and Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9041.
Andrés Lorente-Rodríguez
Svetlana Earnest
Steve Stippec
Xiaofeng Guo
David C Trudgian
Hamid Mirzaei
Melanie H Cobb
The University of Texas Southwestern Medical Center · US

Funding

Cancer Biology Training GrantT32CA124334 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAY, JERRY WILLIAM · 2007 to 2021
$5.3M
REGULATION AND FUNCTION OF STE20-RELATED PROTEIN KINASESR01GM053032 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H. · 1995 to 2012
$4.6M
NCI NIH HHS 2T32 CA124334-06NCI NIH HHS T32 CA124334NIGMS NIH HHS R01 GM053032NIGMS NIH HHS R01 GM53032
6 · The paper itself

Abstract

The Ste20 family protein kinases oxidative stress-responsive 1 (OSR1) and the STE20/SPS1-related proline-, alanine-rich kinase directly regulate the solute carrier 12 family of cation-chloride cotransporters and thereby modulate a range of processes including cell volume homeostasis, blood pressure, hearing, and kidney function. OSR1 and STE20/SPS1-related proline-, alanine-rich kinase are activated by with no lysine [K] protein kinases that phosphorylate the essential activation loop regulatory site on these kinases. We found that inhibition of phosphoinositide 3-kinase (PI3K) reduced OSR1 activation by osmotic stress. Inhibition of the PI3K target pathway, the mammalian target of rapamycin complex 2 (mTORC2), by depletion of Sin1, one of its components, decreased activation of OSR1 by sorbitol and reduced activity of the OSR1 substrate, the sodium, potassium, two chloride cotransporter, in HeLa cells. OSR1 activity was also reduced with a pharmacological inhibitor of mTOR. mTORC2 phosphorylated OSR1 on S339 in vitro, and mutation of this residue eliminated OSR1 phosphorylation by mTORC2. Thus, we identify a previously unrecognized connection of the PI3K pathway through mTORC2 to a Ste20 protein kinase and ion homeostasis.

Indexed as

Adaptor Proteins, Signal TransducingAnalysis of VarianceHeLa CellsHumansImmunoblottingImmunoprecipitationIntracellular Signaling Peptides and ProteinsMechanistic Target of Rapamycin Complex 2Minor Histocompatibility AntigensMultiprotein ComplexesOligonucleotidesOsmotic PressurePhosphoinositide-3 Kinase InhibitorsPhosphorylationProtein Serine-Threonine KinasesRNA, Small InterferingAdaptor Proteins, Signal TransducingIntracellular Signaling Peptides and ProteinsMAPKAP1 protein, humanMechanistic Target of Rapamycin Complex 2Minor Histocompatibility AntigensMultiprotein ComplexesOligonucleotidesOXSR1 protein, humanPhosphoinositide-3 Kinase InhibitorsProtein Serine-Threonine KinasesRNA, Small InterferingSodium-Potassium-Chloride SymportersSorbitolSTK39 protein, humanTOR Serine-Threonine KinasesWNK1 protein, humanWNK Lysine-Deficient Protein Kinase 1Aktion transportphosphoregulationWNK1

Identifiers

PMID24191005
PMCPMC3839713
OpenAlexW2057922534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.